» Articles » PMID: 24018317

Exercise Increases Plasma THC Concentrations in Regular Cannabis Users

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2013 Sep 11
PMID 24018317
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The major psychoactive ingredient of cannabis, Δ(9)-tetrahydrocannabinol (THC) accumulates in fat tissue from where it slowly diffuses back into blood. THC pre-treated rats can show elevated plasma cannabinoid levels when subjected to conditions that promote fat utilization, such as fasting. Here we examine whether fasting and exercise increase plasma THC concentrations in regular cannabis users.

Methods: Fourteen regular cannabis users completed 35 min of exercise on a stationary bicycle in either a fed or overnight fasted state. Plasma cannabinoid levels were assessed prior to exercise, immediately post-exercise and 2h post-exercise. Plasma samples were also analyzed for indices of lipolysis (free fatty acids (FFA) and glycerol).

Results: Exercise induced a small, statistically significant increase in plasma THC levels accompanied by increased plasma FFA and glycerol levels. Exercise-induced increases in plasma THC concentrations were positively correlated with body mass index. Fasting induced a significant increase in plasma FFA levels, and a lowering of blood glucose, but did not significantly alter plasma cannabinoid levels.

Conclusions: Here we demonstrate that exercise enhances plasma THC levels in regular cannabis users. The lack of a fasting effect may reflect the modest duration of fasting used which was associated with only a modest increase in fat utilization relative to exercise. Overall, these results suggest that exercise may elevate blood THC levels by releasing dormant THC from fat stores. These data suggest the interpretation of blood THC levels in roadside and workplace tests might be complicated by recent exercise.

Citing Articles

Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain.

Gazarov E, Zequeira S, Senetra A, Howard J, Sharma A, McCurdy C Front Pharmacol. 2023; 14:1227220.

PMID: 37701025 PMC: 10493391. DOI: 10.3389/fphar.2023.1227220.


Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial.

McCartney D, Suraev A, Doohan P, Irwin C, Kevin R, Grunstein R J Psychopharmacol. 2022; 36(12):1338-1349.

PMID: 35637624 PMC: 9716488. DOI: 10.1177/02698811221095356.


Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue.

Child R, Tallon M Nutrients. 2022; 14(10).

PMID: 35631242 PMC: 9146469. DOI: 10.3390/nu14102101.


Concordance between Self-Reported Drug Use and Urinalysis in a Sample of Black American Women.

McLouth C, Oser C, Stevens-Watkins D Subst Use Misuse. 2022; 57(4):495-503.

PMID: 35067171 PMC: 9100838. DOI: 10.1080/10826084.2021.2019778.


A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window.

DeGregorio M, Wurz G, Montoya E, Kao C Sci Rep. 2021; 11(1):22776.

PMID: 34815467 PMC: 8611040. DOI: 10.1038/s41598-021-02137-x.